Proving Value Is Eucomed’s Top Priority: An Interview With Guy Lebeau
This article was originally published in The Gray Sheet
Executive Summary
Device makers still have a lot of work to do to convince the cost-conscious governments of Europe that their products have strong socioeconomic value, says Eucomed Chairman Guy Lebeau
You may also be interested in...
U.K. Panel Says: Continue DES Use, But Limit Price Premium Over Bare Metal
The United Kingdom's National Institute of Health and Clinical Excellence has retreated from its August 2007 recommendation that the country's National Health Service stop paying for drug-eluting stents after being bombarded with criticism from interventional cardiologists and stent manufacturers
Industry-Supported Tissue, Device Regs Clear European Union Council
The second of two European Union legislative bodies endorsed two regulations impacting medical device oversight last week
First Research Funded By InHealth Speaks Well For ICDs
Research sponsored by the AdvaMed spin-off InHealth suggests that patients with implanted defibrillators enjoy a quality of life similar to people of the same age without ICDs